Cadre Holdings, Inc.·4

Jun 18, 4:18 PM ET

SOKOLOW NICOLAS 4

4 · Cadre Holdings, Inc. · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Cadre (CDRE) Director Nicolas Sokolow Receives Option Grant

What Happened Nicolas Sokolow, a director of Cadre Holdings, Inc. (CDRE), received a grant of options to purchase 17,393 shares of Cadre common stock. The Form 4 reports the acquisition as a derivative award (transaction code A) with an acquisition amount shown as $0.00 (typical for option grants; no cash was paid on grant). The grant was made under Cadre’s 2021 Stock Incentive Plan.

Key Details

  • Transaction date: 2026-06-16; Form 4 filed: 2026-06-18 (filed within the usual 2-business-day window).
  • Reported amount: options covering 17,393 shares (derivative grant); Form shows $0.00 for the acquisition price.
  • Vesting schedule (per footnote): 4,349 options vest on 2026-06-30; 4,348 options vest on each of 2026-09-30, 2026-12-31 and 2027-03-31.
  • Shares owned after the reported transaction: not specified in the provided excerpt of the filing.
  • Transaction code: A = award/grant (derivative security).

Context This was an option grant (compensation award) rather than an open-market purchase or sale. Options give the holder the right to buy shares in the future subject to vesting and exercise terms; the filing does not indicate immediate exercise or sale. Such grants are common for directors as part of compensation and do not by themselves indicate buying or selling sentiment.

Insider Transaction Report

Form 4
Period: 2026-06-16
Transactions
  • Award

    Stock Option (right to purchase)

    [F1]
    2026-06-16+17,39317,393 total
    Exercise: $28.75Exp: 2036-06-16Common Stock (17,393 underlying)
Footnotes (1)
  • [F1]The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,349 shares of the Issuer's Common Stock will vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares of the Issuer's Common Stock will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027, respectively.
Signature
/s/ Nicolas Sokolow|2026-06-18

Documents

1 file
  • 4
    tm2618182-7_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT